Skip to main content

Table 5 Multivariate analysis of DFS and OS according to clinical pathological variables

From: Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases

Variables

DFS

OS

HR

95 % CL

P-value

HR

95 % CL

P-value

Age (years)

≤50 vs. >50

0.786

0.404-1.527

0.477

0.698

0.340-1.432

0.327

Tumor size (cm)a

≤2 vs. >2, ≤5 vs. >5

1.283

0.721-2.281

0.397

1.405

0.760-2.598

0.279

Lymph node stage

negative vs. positive

2.167

0.980-4.796

0.056

2.001

0.864-4.637

0.106

Grade

G1 vs. G2 vs. G3

1.286

0.756-2.186

0.353

1.273

0.722-2.246

0.404

Histological type

IDC vs. ILC vs. Others

0.742

0.422-1.306

0.301

0.651

0.345-1.228

0.185

Combined grouping

others vs. PELP1, Ki-67 double high

2.020

1.022-3.990

0.043

2.380

1.138-4.978

0.021

  1. Abbreviations: LN, lymph node; DFS, disease-free survival; OS, overall survival; HR, hazard ratio; 95 % CL, 95 % confidence interval
  2. Note: afor the variable, data for two cases are unavailable from medical records